Скачать или смотреть NASH management in 2022 | Prof. Stephen Harrison

Prof. Stephen Harrison (USA) discusses state of the art management of non-alcoholic steatohepatitis (NASH) in 2022. He focuses on the benefits of lifestyle recommendations, including nutrition and exercise. He shows that weight loss is associated with NASH resolution and fibrosis regression over time following bariatric surgery in patients with severe obesity and NASH. He mentions that NASH progression to clinical outcomes may take time, hence trials for NASH treatment look at surrogate outcomes (histologic endpoints) which are NASH resolution and/or fibrosis improvement approved by the FDA. Further he explores if NASH is reversible and also looks into the potential targets for NASH treatment.

View full video: https://bit.ly/3PYiD5k

______________________________________

The PanNASH™ initiative aims to increase awareness and disseminate knowledge related to NASH as a multi-system disease with a focus on PPAR agonists among the scientific and clinical community, patients and other key stakeholders within the healthcare system, thus improving the lives of millions of patients worldwide. ✉ Sign-up to receive our newsletter and/or our free science magazine: https://pannash.org/newsletter/ LinkedIn:   / pannash-initiative   Twitter:   / pannash_init   Don't forget to check out more educational NASH video content obtained from expert doctors worldwide: https://pannash.org/videos/